Investigators at the University of Mississippi report the discovery of eleven new non-cannabinoid constituents in cannabis, several of which possess “anti-microbial” (think MRSA), “anti-malarial,” and “anti-leishmanial” (a common skin parasite) activity. Scientists also reported that several of the compounds also possessed anti-inflammatory properties and acted as potent anti-oxidants.
Author: Paul Armentano, NORML Deputy Director
Well what do you know? A mainstream media outlet finally picked up on this story!
Sure it’s been over a week since I first blogged about it here and here. But given the MSM’s long history of sweeping similar medi-pot revelations under the rug, this is case where I gladly say ‘better late than never.’
Both implied that Parliament’s 2004 decision to downgrade pot possession to a verbal warning was responsible for the influx of supposed ‘triple-strength killer weed.’
Turns out Smith and Brown were full of it.
Pelosi’s response is candid yet disappointing. While acknowledging that scientific research clearly supports the medical use of cannabis, Pelosi acknowledges that most of Congress — including many otherwise ‘progressive’ members of the influential Congressional Black Caucus — “just isn’t there yet. … There just isn’t enough support for it.”
There is no ‘confusion’ regarding the legality of California’s pot laws.
There is only arrogance and recalcitrance on the part of those who have chosen to abuse their power and position to hamstring the will of the voters, the legislature, and the courts.
Several years ago, when I first began writing the booklet Emerging Clinical Applications for Cannabis and Cannabinoids, I mused about what sort of advancements in the treatment of disease may have been achieved over the past 70+ years had U.S. government chosen to advance — rather than stifle — clinical research into the therapeutic effects of cannabis.
Now, more than ever, this is a question that our elected officials — both Republican and Democrat — must answer.
Excuse me, but if debating the merits of America’s failed cannabis policy is, in the Drug Czar’s opinion, a topic only appropriate for midnight musings, then why is the White House Office of National Drug Control Policy straining their already diminished intellectual capacities responding to this discussion in The Hill (which, last time I checked, was not a publication frequently read by college students in their dorm rooms at 2 am)??!!
Kudos to The Washington Post for publicizing this important story. And an extra ‘shout out’ to the Post’s editors for highlighting that this trial was sponsored by California’s Center for Medical Cannabis Research and not by the US government.
